Orchestra BioMed Holdings Inc. (OBIO) is a biotechnology company listed on NASDAQ.
Latest reported OBIO revenue for 2026-06-30 was $198.0K. Net income was -$44.4M. Revenue was up 80.0% from 2026-03-31 to 2026-06-30. OBIO currently screens at market cap $231.7M.
Use this OBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the OBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the OBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to Orchestra BioMed Holdings Inc. even when a live quote feed is slow.
Latest cached year on this hub. Full OBIO income, balance, and cash tables.